Showing results (121-130 of 2,551) with videos related to
Sort By:
Pageof 256
ASAIO Transactions|January 1, 1990
Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systemsV Dixit, T M ChangJournal of Dialysis|January 1, 1980
Effects of air and fluid flow rates on removing different concentrations of urea and ammonia from fluid by gas absorption in a capillary hemodialyzerE Pişkin, T M ChangBiomaterials, Artificial Cells, and Artificial Organs|January 1, 1987
Effect of membrane thickness of collodion coated activated charcoal on adsorption of small and middle moleculesD Morley, T M ChangArtificial Cells, Blood Substitutes, and Immobilization Biotechnology|September 29, 2000
Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in-vitro and in-vivoS Prakash, T M ChangArtificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Toxicity of liposomes containing low mol% of dienoyl phosphocholine to blood: use of carboxymethyl chitin to reduce toxicityT Nishiya, T M ChangThe International Journal of Artificial Organs|May 1, 1978
Coated charcoal hemoperfusion for the removal galactose in ratsP Nasielski, T M ChangNature Biotechnology|July 14, 1998
Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant propertiesF D'Agnillo, T M ChangArtificial Cells, Blood Substitutes, and Immobilization Biotechnology|December 14, 1999
Artificial cell microcapsules containing genetically engineered E. coli DH5 cells for in-vitro lowering of plasma potassium, phosphate, magnesium, sodium, chloride, uric acid, cholesterol, and creatinine: a preliminary reportS Prakash, T M ChangMolecular Biotechnology|July 4, 2001
Procedures for microencapsulation of enzymes, cells and genetically engineered microorganismsT M Chang, S PrakashPageof 256